The Long Window of Preclinical Alzheimer’s Disease: Opportunities for Intervention

Posted June 9, 2017

David Holtzman, M.D., joined us for a WebEx conference on Alzheimer’s and the work he is doing to help us better understand and treat the disease.

Share:

Rudy Tanzi, PH.D.: Neuroinflammation and Alzheimer’s Disease

Back to News and Events

Alzstream™ Webinar: Alzheimer’s and the Gut Microbiome

Related Content:

October 7 2022

BLOOD PRESSURE MEDICATION: A FUTURE TREATMENT FOR AD?

October 7 2022

ALTERING THE GUT MICROBIOME IMPACTS AMYLOID IN THE BRAIN

October 7 2022

IMPROVING A MALFUNCTIONING BRAIN DRAIN CLEARS AMYLOID PLAQUES

October 7 2022

IDENTIFIED: AN ELUSIVE TOXIN THAT DAMAGES NEURONS

October 7 2022

POTENTIAL DIAGNOSTIC TOOL: MEASURING NEUROINFLAMMATION IN THE BRAIN

October 7 2022

SOME BRAINS ARE RESILIENT TO ALZHEIMER’S